DIA’s Post

Biopsy Devices Market was valued at US$ 2.91 Bn. in 2022 and is expected to reach US$5.68 Bn. in forecast period and the market size is expected to grow at a CAGR of 10.02% through the forecast period. Click here for free sample + related graphs of the report: https://lnkd.in/g5s4VwtJ The Biopsy Devices Market is advancing rapidly, playing a crucial role in early diagnosis and treatment of various diseases, particularly cancer. Innovations in biopsy technology are enhancing accuracy, minimally invasive procedures, and patient comfort, significantly improving clinical outcomes. As demand for precision medicine rises, these devices are essential in providing reliable diagnostic solutions. Unlock your exclusive PDF now!  https://lnkd.in/dt7ycfTb #BiopsyDevices #MedicalInnovation #Healthcare #CancerDiagnosis #PrecisionMedicine #MedicalDevices #PatientCare #ClinicalOutcomes

Stagnated patient care driven by healthcare data access challenges and staffing shortages have a big impact on clinicians’ time spent with patients. The treatment selection in cancer therapies tend to be more linear, segmented and rather ‘trial and error’-based. The need for efficient data utilisation in healthcare together with a Digital Transformation Vision are critical moving forward to enhance clinical decision making and outcomes in complex multimodal environments.   Join this HSJ webinar in association with GE HealthCare to listen to James Brenton, Jennifer Graystone and Ben Newton discussing how digital transformation can be accelerated to tackle healthcare challenges with advanced molecular and digital tools.   Register here: https://lnkd.in/eqy8bdXe   #HSJModernisingdiagnostics #NHSCancer

Bringing together experts from different fields encourages creativity, enhances patient care, and promotes scientific knowledge. This inclusive approach fosters interdisciplinary teamwork, improves problem-solving skills, and customises tactics to meet the needs of a variety of patients. Accepting diversity is important for more reasons than merely representation; it also helps advance cancer treatments, diagnosis, and treatment planning. #MedPhysics #DiversePerspectives #MedicalPhysicsInnovates #PatientCenteredCare #InclusiveScience #CollaborativeOncology

Get involved in the webinar about accelerating digital transformation by signing up below. #hsj #gehc #NHSCancer #digitaltransformation

Take a Stand Against Lung Cancer with SMS Clinical Research! 🚀 Are you between 50-80 and have a history with smoking? This is your chance to participate in our Lung Cancer Screening Study. Not only can you earn $200 per year, but you also contribute to vital research. 🌟 Ready to get involved for the financial incentive and health benefits? Or, need a bit more info first? Either way, we’re here for you. 📞 Call us at 972-216-5100 or visit https://lnkd.in/ghBtfXny for more details. Your choice can make a world of difference! #FightLungCancer #SMSResearch #EarnAndLearn #HealthHeroesWanted #ClinicalTrials #MedicalResearch #MedicalAdvancement #HealthcareResearch #ScienceInMedicine #ResearchStudy #HealthScience #EvidenceBasedMedicine #MedicalInnovation #DataAnalysis #HealthTech #PharmaResearch #BiomedicalResearch #PublicHealthResearch #MedicalData #HealthcareInnovation #HealthOpportunities #MakeADifference #JoinTheStudies #BetterHealthAhead

Raising awareness amongst GPs and other HCPs that NETs tend to present with non-specific symptoms that may be attributed to an alternative diagnosis is imperative to further improve NET care.  ☑ This is a highlight from the findings on “Global Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients” in the INCA review article, recently published in the Journal of Neuroendocrinology with open access. ✔ The article is based on the findings of the Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (#SCAN), which measured access to diagnostics, treatments and monitoring for neuroendocrine tumor (NET) patients globally.  ✅ Read the article and all other INCA publications here: https://lnkd.in/eQJk_4bw #LetsTalkAboutNETs #NeuroendocrineCancer #SCAN #NETResearch 

🔎 Discover the positive outcomes of BCRC-WA's groundbreaking research on Chemotherapy-Induced Alopecia (CIA). The study explored the efficacy of scalp cooling at two different temperatures, providing valuable insights into enhancing the lives of patients undergoing chemotherapy. Dive deeper into the study and explore the findings on our website: https://lnkd.in/gnMp_zAj #breastcancer #breastcancerresearch #patientimpact #scalpcooling